Erbe USA Cryoprobe Recall - Rupture Risk
Summary
FDA issued a Class I recall for Erbe USA Inc's Flexible Cryoprobe (REF: 20402-411) due to risk of rupture or burst during activation. The recall affects devices distributed nationwide across the US and Puerto Rico. Healthcare providers must immediately cease use of affected devices and return them to the manufacturer.
What changed
FDA classified a Class I (most serious) recall for Erbe USA Flexible Cryoprobe model REF: 20402-411, catalog number 20402-411, due to probes potentially rupturing or bursting during activation. This represents the highest risk category as the defect may cause serious injury or death during surgical procedures. The recall number is Z-1568-2026 and the action is ongoing.
Healthcare providers with these cryoprobes in inventory must immediately quarantine the devices and contact Erbe USA to arrange return. Medical device manufacturers should verify they do not hold affected inventory and notify any downstream distributors. FDA recommends healthcare facilities review their purchasing and usage records to identify potentially impacted devices. No specific return deadline is stated; however, Class I recalls require prompt action given the serious safety risk.
What to do next
- Immediately quarantine and stop using Erbe USA Flexible Cryoprobe REF: 20402-411
- Contact Erbe USA Inc to arrange return of affected devices
- Review purchasing and inventory records to identify affected products and notify downstream customers
Penalties
Class I recall - continued use of defective devices may result in patient injury and potential civil liability
Archived snapshot
Apr 7, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Erbe USA Inc
Device Recalls (Class I)
← All Device Recalls (Class I) Class I Z-1568-2026 · 20260401 · Ongoing
Product
Flexible Cryoprobe (OD 2.4mm, L1.15mm) REF: 20402-411. For surgical use
Reason for Recall
Probes may rupture/burst during activation
Distribution
US Nationwide distribution, including Puerto Rico.
Source: openFDA Enforcement API
Named provisions
Related changes
Get daily alerts for FDA: Device Recalls Class I
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from FDA.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when FDA: Device Recalls Class I publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.